切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2013, Vol. 02 ›› Issue (01) : 34 -38. doi: 10.3877/cma.j.issn.2095-3232.2013.01.008

所属专题: 文献

临床研究

肝细胞肝癌合并原发性胃部非霍奇金淋巴瘤的诊治特点
姚志成1, 刘波1, 李明亮2, 颜见3, 钟跃思3, 邓美海3,()   
  1. 1. 510530 广州,中山大学附属第三医院岭南医院普通外科
    2. 510530 广州,中山大学附属第三医院岭南医院重症监护室
    3. 中山大学附属第三医院肝胆外科
  • 收稿日期:2012-12-07 出版日期:2013-02-10
  • 通信作者: 邓美海
  • 基金资助:
    广东省科技计划项目(2010B031600215)

Characteristic of diagnosis and treatment of hepatocellular carcinoma complicated with primary gastric non-Hodgkin’s lymphoma: a case report

Zhi-cheng YAO1, Bo LIU1, Ming-liang LI2, Jian YAN3, Yue-si ZHONG3, Mei-hai DENG3,()   

  1. 1. Department of General Surgery, Lingnan Hospital, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510530, China
  • Received:2012-12-07 Published:2013-02-10
  • Corresponding author: Mei-hai DENG
  • About author:
    Corresponding author: DENG Mei-hai, Email:
引用本文:

姚志成, 刘波, 李明亮, 颜见, 钟跃思, 邓美海. 肝细胞肝癌合并原发性胃部非霍奇金淋巴瘤的诊治特点[J/OL]. 中华肝脏外科手术学电子杂志, 2013, 02(01): 34-38.

Zhi-cheng YAO, Bo LIU, Ming-liang LI, Jian YAN, Yue-si ZHONG, Mei-hai DENG. Characteristic of diagnosis and treatment of hepatocellular carcinoma complicated with primary gastric non-Hodgkin’s lymphoma: a case report[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2013, 02(01): 34-38.

目的

探讨肝细胞肝癌(肝癌)合并原发性胃部非霍奇金淋巴瘤(PGNHL)的诊治特点。

方法

回顾性研究2006年10月中山大学附属第三医院收治的1例肝癌合并PGNHL患者。患者已签署知情同意书,符合医学伦理学规定。分析其病史、诊治经过、治疗方法、疗效和血常规、肝功能、病毒血清学、腹部超声、计算机体层摄影术(CT)和电子胃镜等临床资料,总结该病诊治特点。

结果

该例患者男性,76岁,因进行性疲劳并食欲减退1个月入院。既往有30年的乙型肝炎病毒(HBV)感染史。术前腹部超声及CT检查结果均考虑胃癌肝转移,电子胃镜检查示胃腔内巨大肿块,活体组织检查(活检)示低分化腺癌。入院后经积极术前准备在气管插管全身麻醉下行全胃、肝左外叶、脾切除以及胰尾部肿瘤根治性切除术。术后病理检查示胃部弥漫性大B细胞淋巴瘤、肝脏中分化肝癌。术后给予化学药物治疗(化疗)。出院后随访67个月,无复发征象。

结论

该例肝癌合并PGNHL的发生可能与HBV长期感染密切相关,无特征性临床表现,诊断主要靠病理学确诊。根治性切除手术是延长患者长期生存期的重要手段。

Objective

To explore the characteristic of diagnosis and treatment of hepatocellular carcinoma (HCC) complicated with primary gastric non-Hodgkin’s lymphoma(PGNHL).

Methods

Retrospective analysis was performed in one patient who was diagnosed with HCC complicated with PGNHL in the Third Affiliated Hospital of Sun Yat-sen University in October 2006. Local ethical committee approval had been received and that the informed consent of the subject was obtained. The clinical data including case history, treatment procedures, efficacy, blood routine, liver function, viral serology, abdominal ultrasound, abdominal computed tomography(CT), electronic gastroscopy examination as well as treatment were analyzed and the treatment characteristics were summarized.

Results

The patient (male,76 years old) was admitted in hospital for progressive fatigue and loss of appetite with a 30-year hepatitis B virus infection history. Both preoperative abdominal ultrasound and CT indicated gastric cancer with liver metastasis. The electronic gastroscope test showed huge mass in the gastral cavity. The biopsy indicated poorly differentiated adenocarcinoma. The patient underwent total gastrectomy and resection of all metastasis including left lateral lobe of liver, spleen and the tail of pancreas. The postoperative pathological examination demonstrated two different pathological types: gastric diffuse large B-cell lymphoma and moderately-differentiated HCC. The patient received chemotherapy and was followed up for 67 months after the operation. No recurrence was observed.

Conclusions

HCC complicated with PGNHL is rare and might be closely related to the long-term hepatitis B virus(HBV) infection. Patients with HCC and PGNHL have no specific clinical manifestations. The diagnosis is confirmed by pathological examination. Radical resection is the preferred treatment for better prgonosis.

图1 肝细胞肝癌合并原发性胃部非霍奇金淋巴瘤患者的术前腹部超声检查图像
图2 肝细胞肝癌合并原发性胃部非霍奇金淋巴瘤患者的术前腹部CT扫描图像
图3 肝细胞肝癌合并原发性胃部非霍奇金淋巴癌患者手术切除大体标本
图4 肝细胞肝癌合并原发性胃部非霍奇金淋巴癌患者手术切除物的病理检查(HE,×200)
表1 PubMed数据库中肝癌并发NHL病例一览表
[1]
Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010, 127(12):2893-2917.
[2]
El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 2012, 142(6):1264-1273.
[3]
Amin J, Dore GJ, O’Connell DL, et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol, 2006, 45(2):197-203.
[4]
Marcucci F, Mele A, Spada E, et al. High prevalence of hepatitis B virus infection in B-cell non-Hodgkin’s lymphoma. Haematologica, 2006, 91(4):554-557.
[5]
Kim JH, Bang YJ, Park BJ, et al. Hepatitis B virus infection and B-cell non-Hodgkin’s lymphoma in a hepatitis B endemic area: a case-control study. Jpn J Cancer Res, 2002, 93(5):471-477.
[6]
Bosch FX, Ribes J, Díaz M, et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology, 2004, 127(5 Suppl 1):S5-S16.
[7]
Ennibi K, Mikdame M, Rabhi M, et al. Primary gastric lymphoma: a retrospective series of 35 cases. Tunis Med(法文), 2008, 86(5):457-462.
[8]
Müller AM, Ihorst G, Mertelsmann R, et al. Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol, 2005, 84(1):1-12.
[9]
Cavanna L, Civardi G, Fornari F, et al. Simultaneous relapse of liver cell carcinoma and non-Hodgkin’s lymphoma in the liver. report of a case with diagnosis by ultrasonically guided fine needle aspiration biopsy. Acta Cytol, 1994, 38(3):451-454.
[10]
Shikuwa S, Ito M, Nakashima M, et al. Autopsy case of colocalized tumors of hepatocellular carcinoma and malignant lymphoma. J Gastroenterol, 1996, 31(1):129-132.
[11]
Suriawinata A, Ye MQ, Emre S, et al. Hepatocellular carcinoma and non-Hodgkin lymphoma in a patient with chronic hepatitis C and cirrhosis. Arch Pathol Lab Med, 2000, 124(10):1532-1534.
[12]
Takeshima F, Kunisaki M, Aritomi T, et al. Hepatic mucosa-associated lymphoid tissue lymphoma and hepatocellular carcinoma in a patient with hepatitis B virus infection. J Clin Gastroenterol, 2004, 38(9):823-826.
[13]
Kataoka TR, Tsukamoto Y, Kanazawa N, et al. Concomitant hepatocellular carcinoma and non-Hodgkin’s lymphoma in a patient with nodular regenerative hyperplasia. Pathol Int, 2006, 56(5):279-282.
[14]
Himoto T, Miyauchi Y, Nomura K, et al. Coexistence of splenic non-Hodgkin’s lymphoma with hepatocellular carcinoma in a patient with chronic hepatitis C. Dig Dis Sci, 2006, 51(1):70-76.
[15]
Ohtsubo K, Oku E, Imamura R, et al. Simultaneous hepatic relapse of non-Hodgkin’s lymphoma and hepatocellular carcinoma in a patient with hepatitis C virus-related cirrhosis. Acta Haematol, 2006, 116(4):266-271.
[16]
Lin A, Kadam JS, Bodenheimer HC, et al. Concomitant diffuse large B-cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: a study of two cases. J Med Virol, 2008, 80(8):1350-1353.
[17]
Utsunomiya T, Okamoto M, Tsujita E, et al. Hepatocellular carcinoma infiltrated with non-Hodgkin’s lymphoma: report of a case. Surg Today, 2009, 39(11):1010-1012.
[18]
Heidecke S, Stippel DL, Hoelscher AH, et al. Simultaneous occurrence of a hepatocellular carcinoma and a hepatic non-Hodgkin’s lymphoma infiltration. World J Hepatol, 2010, 2(6):246-250.
[19]
Chong VH, Idros A, Telisinghe PU. Triple synchronous gastrointestinal malignancies: a rare occurrence. Singapore Med J,2010, 51(10):e176-e177.
[1] 丁科, 张亚琼, 刘杰, 邓莉平, 张永喜, 熊勇. 获得性免疫缺陷综合征相关淋巴瘤患者的临床特征及生存状况的变化趋势[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 278-284.
[2] 中国医师协会肝癌专业委员会. 肝细胞癌伴微血管侵犯诊断和治疗中国专家共识(2024版)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 313-324.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[5] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[6] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[7] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[8] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[9] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[10] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[11] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[12] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[13] 邓万玉, 陈富, 许磊波. 肝硬化与非肝硬化乙肝相关性肝癌患者术后无复发生存比较及其影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 670-674.
[14] 王向前, 李清峰, 陈磊, 丘文丹, 姚志成, 李熠, 吴荣焕. 姜黄素抑制肝细胞癌索拉非尼耐药作用及其调控机制[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 729-735.
[15] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?